Related Experiment Video
Updated: Apr 3, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
4.5K
INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME
Shelley Day1, Jose A Martinez, Peter A Nixon
1Austin Retina Associates, Austin, Texas.
Retina (Philadelphia, Pa.)
|September 19, 2015
Summary
Intravitreal sulfur hexafluoride gas injection effectively released vitreomacular traction (VMT) in over half of patients. This minimally invasive treatment offers a low-cost alternative for VMT syndrome, with some eyes showing macular hole closure and reduced retinal thickness.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Innovation
Background:
- Vitreomacular traction (VMT) syndrome can lead to vision impairment.
- Current treatments like vitrectomy or ocriplasmin injections are invasive and expensive.
Purpose of the Study:
- To assess the efficacy of intravitreal sulfur hexafluoride gas injection for treating symptomatic VMT syndrome.
- To evaluate this minimally invasive, low-cost treatment option.
Main Methods:
- A retrospective case series of 9 patients with symptomatic VMT.
- Patients received an intravitreal injection of 0.3 mL of 100% sulfur hexafluoride gas.
- Outcomes measured included VMT release, visual acuity, and retinal thickness via spectral domain optical coherence tomography (SD-OCT) at 1 month.
Main Results:
- VMT release was observed in 55.6% of eyes by 1 month post-injection.
- Mean visual acuity showed a slight, non-significant improvement.
- Central subfield thickness decreased significantly (P = 0.004).
- Two Stage I macular holes closed post-injection.
Conclusions:
- Intravitreal sulfur hexafluoride gas injection is a viable, low-cost, and minimally invasive treatment for VMT syndrome.
- Further research is recommended to confirm these findings.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K